当前位置:首页 - 行情中心 - 同和药业(300636) - 财务分析

同和药业

(300636)

  

流通市值:22.04亿  总市值:25.20亿
流通股本:3.67亿   总股本:4.20亿

同和药业(300636)财务分析

利润表
报告期2026-09-302026-06-302026-03-312025-12-31
营业总收入608,217,884.31383,163,489.97184,392,671.37828,659,350.98
营业总成本562,366,220.33357,376,905.98167,876,632.18702,520,673.31
其他经营收益
营业利润33,396,256.6920,080,426.0419,615,993.974,894,385.22
利润总额33,923,321.3620,577,856.319,615,993.975,576,727.44
净利润38,457,282.8624,570,982.6318,779,502.7173,091,433.31
每股收益
其他综合收益----
综合收益总额38,457,282.8624,570,982.6318,779,502.7173,091,433.31
资产负债表
报告期2026-09-302026-06-302026-03-312025-12-31
流动资产:
流动资产合计1,051,165,386.461,298,219,464.851,433,803,022.481,461,727,700.92
非流动资产:
非流动资产合计1,876,721,461.121,880,361,088.441,877,817,922.381,859,305,914.44
资产总计2,927,886,847.583,178,580,553.293,311,620,944.863,321,033,615.36
流动负债:
流动负债合计396,273,886.92673,186,757.07787,920,144.82666,921,271.86
非流动负债:
非流动负债合计144,719,090.01132,386,225.8139,686,649.74288,877,695.91
负债合计540,992,976.93805,572,982.87927,606,794.56955,798,967.77
所有者权益(或股东权益):
归属于母公司股东权益合计2,386,893,870.652,373,007,570.422,384,014,150.32,365,234,647.59
股东权益合计2,386,893,870.652,373,007,570.422,384,014,150.32,365,234,647.59
负债和股东权益合计2,927,886,847.583,178,580,553.293,311,620,944.863,321,033,615.36
现金流量表
报告期2026-09-302026-06-302026-03-312025-12-31
经营活动产生的现金流量:
经营活动现金流入小计634,761,415.8403,830,605.75194,284,667.55830,137,521.27
经营活动现金流出小计472,549,827.19312,708,929.83171,822,012.65628,066,783.76
经营活动产生的现金流量净额162,211,588.6191,121,675.9222,462,654.9202,070,737.51
投资活动产生的现金流量:
投资活动现金流入小计868,301,428.25454,872,959.17164,277,519.35600,038,022.72
投资活动现金流出小计659,392,606.15410,632,134.62298,197,822.39616,946,774.65
投资活动产生的现金流量净额208,908,822.144,240,824.55-133,920,303.04-16,908,751.93
筹资活动产生的现金流量:
筹资活动现金流入小计228,149,653122,997,05359,712,000469,890,512.13
筹资活动现金流出小计706,825,639.72328,554,751.1686,664,175.71567,855,028.09
筹资活动产生的现金流量净额-478,675,986.72-205,557,698.16-26,952,175.71-97,964,515.96
汇率变动对现金及现金等价物的影响-8,156,247.95-6,535,543.07-4,187,012.02233,576.1
现金及现金等价物净增加额-115,711,823.96-76,730,740.76-142,596,835.8787,431,045.72
期末现金及现金等价物余额137,131,459.52176,112,542.72110,246,447.61252,843,283.48
补充资料:
现金及现金等价物的净增加额--76,730,740.76-87,431,045.72
最新报告期:2026-09-08
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中泰证券祝嘉琦0.120.200.262026-09-08
华创证券郑辰,王宏雨0.210.260.312026-09-04
TOP↑